Rapt Therapeutics Inc (NASDAQ:RAPT)
| 29.00 Delayed Data As of 9:32am ET |  -1.00 / -3.33%Today’s Change | 11.85 Today|||52-Week Range 51.21 | +5.03% Year-to-Date |
Latest RAPT News | Press Releases
No recent news for Rapt Therapeutics Inc.
Today’s Trading
| Previous close | 30.00 |
| Today’s open | 30.94 |
| Day’s range | 29.00 - 31.31 |
| Volume | 8,201 |
| Average volume (3 months) | 103,083 |
| Market cap | $734.0M |
Data as of 9:32am ET, 02/24/2020
Growth & Valuation
| Earnings growth (last year) | -24.15% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RTRXRetrophin Inc | -0.78 | -4.51% |
| ANIPANI Pharmaceuticals ... | -1.43 | -2.33% |
| ATRAAtara Biotherapeutic... | -1.05 | -7.96% |
| RUBYRubius Therapeutics ... | -0.57 | -6.57% |
Data as of 9:49am ET, 02/24/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.72 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$36.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
